184 related articles for article (PubMed ID: 22214516)
1. Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation.
Chen Y; Legan SK; Mahan A; Thornton J; Xu H; Schwarz MA
Respir Res; 2012 Jan; 13(1):1. PubMed ID: 22214516
[TBL] [Abstract][Full Text] [Related]
2. Endothelial monocyte activating polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis.
Schwarz MA; Zhang F; Gebb S; Starnes V; Warburton D
Mech Dev; 2000 Jul; 95(1-2):123-32. PubMed ID: 10906456
[TBL] [Abstract][Full Text] [Related]
3. Unbiased Quantitation of Alveolar Type II to Alveolar Type I Cell Transdifferentiation during Repair after Lung Injury in Mice.
Jansing NL; McClendon J; Henson PM; Tuder RM; Hyde DM; Zemans RL
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):519-526. PubMed ID: 28586241
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
6. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
Murray JC; Heng YM; Symonds P; Rice K; Ward W; Huggins M; Todd I; Robins RA
J Leukoc Biol; 2004 May; 75(5):772-6. PubMed ID: 14982944
[TBL] [Abstract][Full Text] [Related]
7. Endothelial monocyte-activating polypeptide II causes NOS-dependent pulmonary artery vasodilation: a novel effect for a proinflammatory cytokine.
Tsai BM; Wang M; Clauss M; Sun P; Meldrum DR
Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R767-71. PubMed ID: 15155281
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I stimulates differentiation of ATII cells to ATI-like cells through activation of Wnt5a.
Ghosh MC; Gorantla V; Makena PS; Luellen C; Sinclair SE; Schwingshackl A; Waters CM
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(3):L222-8. PubMed ID: 23709620
[TBL] [Abstract][Full Text] [Related]
9. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
[TBL] [Abstract][Full Text] [Related]
10. Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).
Lal CV; Schwarz MA
Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):180-8. PubMed ID: 24619875
[TBL] [Abstract][Full Text] [Related]
11. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.
Schwarz MA; Kandel J; Brett J; Li J; Hayward J; Schwarz RE; Chappey O; Wautier JL; Chabot J; Lo Gerfo P; Stern D
J Exp Med; 1999 Aug; 190(3):341-54. PubMed ID: 10430623
[TBL] [Abstract][Full Text] [Related]
12. Transdifferentiation of alveolar epithelial type II to type I cells is controlled by opposing TGF-β and BMP signaling.
Zhao L; Yee M; O'Reilly MA
Am J Physiol Lung Cell Mol Physiol; 2013 Sep; 305(6):L409-18. PubMed ID: 23831617
[TBL] [Abstract][Full Text] [Related]
13. Defining signals that promote human alveolar type I differentiation.
Li Y; Prakash YS; Tan Q; Tschumperlin D
Am J Physiol Lung Cell Mol Physiol; 2024 Apr; 326(4):L409-L418. PubMed ID: 38349124
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs following injury: identification of alveolar intermediate cell types.
Clegg GR; Tyrrell C; McKechnie SR; Beers MF; Harrison D; McElroy MC
Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L382-90. PubMed ID: 15849211
[TBL] [Abstract][Full Text] [Related]
15. Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.
Kayton ML; Libutti SK
Curr Opin Investig Drugs; 2001 Jan; 2(1):136-8. PubMed ID: 11527006
[TBL] [Abstract][Full Text] [Related]
16. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
[TBL] [Abstract][Full Text] [Related]
17. Breaking the in vitro alveolar type II cell proliferation barrier while retaining ion transport properties.
Bove PF; Dang H; Cheluvaraju C; Jones LC; Liu X; O'Neal WK; Randell SH; Schlegel R; Boucher RC
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):767-76. PubMed ID: 24191670
[TBL] [Abstract][Full Text] [Related]
18. Enolase 1 (ENO1) and protein disulfide-isomerase associated 3 (PDIA3) regulate Wnt/β-catenin-driven trans-differentiation of murine alveolar epithelial cells.
Mutze K; Vierkotten S; Milosevic J; Eickelberg O; Königshoff M
Dis Model Mech; 2015 Aug; 8(8):877-90. PubMed ID: 26035385
[TBL] [Abstract][Full Text] [Related]
19. Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia.
Quintos-Alagheband ML; White CW; Schwarz MA
Antioxid Redox Signal; 2004 Feb; 6(1):137-45. PubMed ID: 14713345
[TBL] [Abstract][Full Text] [Related]
20. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
